88.10USD-2.60%Mkt Cap: 6.01B USDP/E: —Last update: 2026-06-01
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases in the United States and internationally. The company's lead product candidate is IMCIVREE (setmelan…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap6.01B USD
Enterprise Value5.94B USD
Revenue (TTM)217.16M USD
Gross Profit170.26M USD
Net Income (TTM)-196.54M USD
Revenue/Share3.280 USD
Last Price88.10 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees414
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-77.70
PEG—
EV/EBITDA-30.28
EV/Revenue27.35
P/S27.87
P/B42.69
EPS (TTM)-3.13
EPS (Forward)-1.14
52W Range
60.3245% of range122.20
52W High122.20 USD
52W Low60.32 USD
Profitability
Gross Margin89.73%
Oper. Margin-87.11%
EBITDA Margin-90.33%
Profit Margin-103.57%
ROE-72.79%
ROA-40.93%
Growth
Revenue Growth83.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-115.67M USD
CapEx (TTM)953.00K USD
FCF Margin-69.38%
FCF Yield-2.51%
Net Debt-228.32M USD
Net Debt/EBITDA1.16
Balance Sheet
Debt/Equity0.01
Current Ratio4.17
Quick Ratio3.63
Book Value/Sh2.069 USD
Cash/Share4.970 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)138.20 USD
Target Range105.00 USD – 159.00 USD
# Analysts15
Ownership
Shares Out.68.53M
Float55.70M
Insiders0.77%
Institutions109.97%
Short Interest
Short Ratio10.7d
Short % Float12.18%
Short % Out.12.09%
Shares Short8.28M
Short (prev mo.)7.83M
Technical
SMA 5087.29 (+0.9%)
SMA 20098.60 (-10.6%)
Beta1.94
S&P 52W Chg27.70%
Avg Vol (30d)666.42K
Avg Vol (10d)543.98K
Technical Indicators
RSI (14)51.6
MACD0.7979
MACD Signal0.7690
MACD Hist.+0.0288
BB Upper97.90 USD
BB Middle90.55 USD
BB Lower83.20 USD
BB Width16.23%
ATR (14)4.091 USD
Vol Ratio (20d)0.35x